Would you like to participate in a clinical research trial?

A clinical trial is a research study in human volunteers used to determine whether new drugs or treatments are safe and effective. Clinical testing is preceded by extensive laboratory research, and is normally done in three phases. Participants can help themselves and others by contributing to medical research and advancing the development of better treatments. The potential benefits and risks should be weighed carefully before entering a clinical trial. Explore the resources below to learn more.

Where to find clinical trials

The following information is presented as a service to those who might be interested in participating in clinical research trials studying atopic dermatitis/eczema. The National Eczema Association (NEA) posts research notices as an informational service only. Such postings do not represent a NEA endorsement of these studies, but serves to make you aware that this clinical study is available for your participation if you choose. If you are presently under the care of a physician for atopic dermatitis/eczema, or other conditions, you should discuss this study with your doctor before altering your treatment program.

Postdate: April 9, 2009

Study Title: Atopic Dermatitis Education Survey

We are conducting a survey on atopic dermatitis education. We hope the results will be published in a peer-reviewed journal. Please follow this link to participate in the Survey:

Principal Investigators: Mikael Langner, M.D. and Howard Maibach, M.D., University of California at San Francisco

Postdate: January 19, 2009

Study Title: HANDEL (HAND Eczema research of aLitretinoin)

Basilea Pharmaceutical HANDEL Clinical Study (HAND Eczema research of aLitretinoin study) has opened for enrollment. There are currently no approved agents in the United States for the treatment of patients with severe CHE that have failed to respond to potent topical steroids. The HANDEL study is a double-blind, placebo-controlled, randomized clinical trial that will investigate the efficacy and safety of alitretinoin in the treatment of patients with severe CHE who have not responded to potent topical steroids. In the HANDEL study participants will be randomized to receive oral alitretinoin or placebo for up to 24 weeks.

Read More in Adobe PDF Format

Postdate: December 30, 2008

Study Title: Does Your Atopic Dermatitis (Eczema) Interfere With Your Sleep?

Sleep Disturbance in Atopic Dermatitis: a comprehensive investigation of opiates, neuropeptides, barrier function, scratching and sleep physiology.

We are studying a medication which is FDA-approved for insomnia, in persons whose atopic dermatitis interferes with their sleep (due to excessive itching and scratching).

Dr. Bruce Bender, Principal Investigator / Amanda Calhoun, Study Coordinator

To be eligible you must:

• Be between the ages of 18-60 with mild to moderate atopic dermatitis
• Have itching and/or scratching affected areas that interferes with sleep
• And must be willing to participate in the study for 4 to 5 weeks with visits occurring 3 times

Qualified participants may receive physical examinations, ECG's, EEG’s, skin testing, and study drug at no cost. In addition, participants who qualify to participate in the study will be financially compensated.

For further information: Please contact our patient recruiters at 303.270.2222

Contact:
Patient Recruiters
National Jewish Medical and Research Center
1400 Jackson Street
Denver, Colorado 80206
Phone: 303.270.2222

Postdate: December 30, 2008

Study Title: Atopic Dermatitis (Eczema) Heart Rate Patterns

Purpose: The purpose of this research is to study heart rate patterns in people with moderate to severe atopic dermatitis and how itching affects those patterns.

To qualify you must:

• be 18-50 years of age, and have a diagnosis of atopic dermatitis (eczema) on at least one forearm or
• be 18-50 years of age, and be healthy (for the healthy control group)

Length/duration of participant involvement: Your participation may last up to 2 visits.

Location:

Wake Forest University School of Medicine
Dermatology Department, Clinical Studies Center
Janeway Tower, 9th floor

Qualifying participants may receive:

• Research study related visits
• Research study related examinations
• Research study related skin evaluations

Compensation: Qualified participants will be financially compensated up to $75. If you withdraw for any reason from the study before completion you will be paid $25 for completing the first study visit.

Whom to contact: Susie Dowd and Penny Bowden (336) 716-3775

DISCLAIMER

The National Eczema Association (NEA) announces research as an informational service to its members. This announcement does not represent a NEA endorsement of this study, but makes you aware that this clinical study is available for your participation if you choose. If you are presently under the care of a physician for atopic dermatitis/eczema or other conditions, you should discuss this study with your doctor before altering your treatment program.

Other Clinical Trials

Clinicaltrials.gov is a registry of federally or privately supported clinical trials conducted in the United States and around the world.